XML 29 R16.htm IDEA: XBRL DOCUMENT
v3.20.4

FDA Refunds | 12 Months Ended
--- | ---
Sep. 30, 2020
FDA Refund [Abstract] |
FDA REFUNDS | 9. FDA REFUNDS On August 29, 2018, the Company received notification from the Food and Drug Administration ("FDA") that the Company was being refunded $818,343 of 2016 product and establishment fees because the fees paid by the Company exceeded the costs of the FDA's review of the associated applications. The Company recorded the $818,343 receivable as other income during the year ended September 30, 2018 and received the refund on October 1, 2018. In November 2019, the Company received an additional $110,207 refund from the FDA for 2016 product and establishment fees because the fees paid by the Company exceeded the costs of the FDA's review of the associated applications. The Company recorded the $110,207 as other income during the year ended September 30, 2020.

X
- References No definition available. + Details
Name: | ctxr_FdaRefundAbstract
Namespace Prefix: | ctxr_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ctxr_FdaRefundDisclosureTextBlock
Namespace Prefix: | ctxr_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration